Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma in Patients with Cirrhosis: Evaluation of Damage to Nontumorous Liver Tissue—Long-term Prospective Study
- 1 April 2000
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 215 (1), 123-128
- https://doi.org/10.1148/radiology.215.1.r00ap21123
Abstract
To evaluate damage to cirrhotic liver tissue after transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). TACE was performed in 111 patients with HCC that involved less than 30% of the liver. Baseline liver function was evaluated with Child-Pugh scores and other indicators. Eighty-two patients had Child-Pugh class A disease, 27 had class B disease, and two had class C disease. All patients underwent chemotherapy followed by gelatin sponge particle embolization in the proper ("complete" embolization; n = 69) or right or left main ("partial" embolization; n = 42) hepatic artery. Liver function was assessed 4 months later, and 95 patients underwent a second TACE (complete embolization in 57, partial in 38). Liver function was again assessed 4 months later in 60 patients. No patient died. Child-Pugh scores increased in all patients from a mean 5.96 to 6.28 (not significant) and 6.51 (P =. 05) after first and second TACEs, respectively. In patients with class A disease, scores increased from a mean 5.37 to 5.73 (P =.01) and 5.89 (P =.001) after first and second TACEs, respectively; in patients with class B disease, scores changed from a mean of 7.48 to 7.67 and 7.30 after first and second TACEs, respectively (not significant). TACE does not induce significant long-term worsening of liver function in patients with class A or B cirrhosis.This publication has 38 references indexed in Scilit:
- Unresectable hepatocellular carcinoma in cirrhosisDigestive Diseases and Sciences, 1996
- Is Preoperative Hepatic Arterial Chemoembolization Safe and Effective for Hepatocellular Carcinoma?Annals of Surgery, 1996
- Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinomaJournal of Hepatology, 1996
- Therapy of Unresectable Hepatocellular CarcinomaThe New England Journal of Medicine, 1995
- Risk factors for intrahepatic recurrence in human small hepatocellular carcinomaGastroenterology, 1995
- Treatment of small hepatocellular carcinomasThe Lancet, 1992
- Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusionCancer, 1991
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990
- Changes in hepatic functional reserve after transcatheter embolization of hepatocellular carcinoma: Assessment by maximal removal rate of indocyanine greenJournal of Hepatology, 1988
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973